FDA Issues Pediatric Warning for Copegus


Copegus (ribavirin) tablets

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)

August 2015

WARNINGS AND PRECAUTIONS

Impact on Growth in Pediatric Patients


ADVERSE REACTIONS

Growth Inhibition in Pediatric Subjects
Source:  http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm218877.htm

Labels: , , ,